On October 29, 2021, Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, announced the acquisition of Misonix, a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. The current Misonix product offerings are state-of-the-art technologies that are supported by next ...

Misonix BoneScalpel is the only ultrasonic device to date to offer blunt blades for frontal insertion into the bone similar to an osteotome. This allows for powerful

DURHAM, NC – October 29, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed the acquisition of Misonix, Inc. (“Misonix”), a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that are designed to enhance ...

2021年7月29日 · Under the terms of the agreement, which has been unanimously approved by the boards of directors of both Bioventus and Misonix, Misonix stockholders will receive aggregate consideration that values Misonix at approximately $518 million on a fully diluted basis (based on Bioventus’ 7-day volume-weighted average stock price (VWAP) of $16.6284 ...

Misonix, Inc.(纳斯达克股票代码:MSON)主要设计、开发、制造和销售用于精确去除硬和软组织的超声医疗设备，包括骨移除、伤口清创和超声抽吸。 其专利超声医疗设备被用于越来越多的医疗领域，包括脊柱外科，神经外科，整形外科，美容手术，腹腔镜手术等。

Surgical orthobiologics portfolio which offers a wide variety of bone graft solutions (allograft, cell and bone marrow, synthetic) to meet the needs of any surgeon and their patients, across a broad range of patient needs, procedures, and costs.

2016年10月19日 · Misonix, Inc. 及其子公司在美国和国际上设计、开发、制造和销售微创外科超声医疗设备。 Misonix产品包括： BoneScalpel：一种用于外科手术的超声骨骼切割系统，该系统包括精确切割骨骼同时保留软组织； BoneScalpel MIS System：是Misonix BoneScalpel系统系列中 …

2021年7月29日 · Misonix’ wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of...

2021年10月26日 · DURHAM, NC and FARMINGDALE, NY – October 26, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that enhance clinical ...

Misonix, Inc.(纳斯达克 股票代码:MSON)主要设计、开发、制造和销售用于精确去除硬和软组织的超声医疗设备，包括骨移除、伤口清创和超声抽吸。 其专利超声医疗设备被用于越来越多的医疗领域，包括 脊柱外科，神经外科，整形外科，美容手术，腹腔镜手术 等。